•
Jun 30, 2021
Johnson & Johnson Q2 2021 Earnings Report
Johnson & Johnson's diversified portfolio drove strong sales and earnings growth across its Medical Device, Consumer Health, and Pharmaceutical businesses.
Key Takeaways
Johnson & Johnson reported strong second-quarter results with sales growth of 27.1% to $23.3 billion and EPS of $2.35, a 72.8% increase. The company is increasing its 2021 full-year guidance for sales and EPS.
Strong sales growth of 27.1% to $23.3 Billion in Second Quarter 2021.
Operational growth of 23.0%.
EPS of $2.35 increased 72.8% in Second Quarter 2021.
Adjusted EPS of $2.48 increased 48.5%.
Company increasing 2021 Full-Year guidance for sales and EPS
Johnson & Johnson
Johnson & Johnson
Forward Guidance
Johnson & Johnson is increasing its 2021 full-year guidance for sales and EPS.